What strategies should be employed to prevent myocardial ischemia in the peri‑operative period after coronary artery bypass grafting?

Avoiding Myocardial Ischemia After CABG

Beta-blockers are the cornerstone intervention for preventing perioperative myocardial ischemia after CABG and should be administered at least 24 hours preoperatively, reinstituted immediately postoperatively, and continued indefinitely at hospital discharge in all patients without contraindications. 1

Beta-Blocker Strategy (Class I Recommendation)

The evidence is unequivocal from the 2011 ACCF/AHA guidelines that beta-blockers directly reduce perioperative myocardial ischemia 1. The algorithmic approach is:

• Preoperatively: Start beta-blockers at least 24 hours before surgery in all patients without contraindications
• Intraoperatively: Continue therapy throughout the procedure
• Postoperatively: Reinstitute as soon as clinically possible (use IV formulation if patient cannot take oral medications) 1
• At discharge: Prescribe indefinitely to all patients

The mortality benefit extends to all patient subgroups, even those without perioperative myocardial ischemia or heart failure, with Canadian data showing reduced mortality over 75 months of follow-up (2.8% vs 3.4% mortality) 1. This Class IIa recommendation specifically states beta-blockers are effective in reducing perioperative myocardial ischemia 1.

Important Caveat for Beta-Blockers

In patients with LVEF <30%, the mortality benefit is uncertain 1. However, for those with LVEF >30%, preoperative beta-blockers effectively reduce in-hospital mortality. The 2019 ESC/EACTS guidelines reinforce perioperative oral beta-blocker therapy for post-operative atrial fibrillation prevention, which indirectly protects against ischemic complications 2.

ACE Inhibitors/ARBs Strategy (Class I Recommendation)

ACE inhibitors or ARBs should be reinstituted postoperatively once the patient is hemodynamically stable 1. The algorithm is:

• If already on therapy preoperatively: Reinstitute postoperatively once stable
• If not on therapy preoperatively: Initiate postoperatively and continue indefinitely in patients with:
  • LVEF ≤40%
  • Hypertension
  • Diabetes mellitus
  • Chronic kidney disease

Critical pitfall: The safety of continuing ACE inhibitors/ARBs preoperatively is uncertain due to potential hypotension during surgery 1. The guidelines explicitly state this as Class IIb (uncertain safety). Therefore, hold these medications preoperatively but aggressively reinitiate them postoperatively once hemodynamically stable.

For low-risk patients (normal LVEF, well-controlled risk factors), it is reasonable to initiate ACE inhibitors/ARBs postoperatively and continue indefinitely (Class IIa) 1.

Hemodynamic Optimization

Beyond pharmacotherapy, preventing myocardial ischemia requires meticulous attention to:

• Heart rate control: Reduction in heart rate increases oxygen supply and reduces demand—beta-blockers are the most effective means 3
• Preserve coronary perfusion pressure: Maintain adequate diastolic blood pressure; decreases in diastolic pressure with severe stenoses reduce coronary blood flow. Use fluid resuscitation or phenylephrine if needed 3
• Avoid tachycardia and sympathetic surges: Appropriate opioid or volatile anesthetic use to blunt stress response 3

Additional Cardioprotective Considerations

The 2024 review highlights that while cardioplegia is the intraoperative cornerstone 4, perioperative strategies include:

• Anesthetic agent selection: Volatile anesthetics have cardioprotective properties through preconditioning mechanisms 4, 5
• Tight glycemic control 4
• Optimization of respiratory parameters during aortic unclamping to limit reperfusion injury 4
• Remote ischemic preconditioning (though clinical application remains limited) 4

Long-Term Secondary Prevention

Statins and smoking cessation are critical for long-term outcomes 6, 7. High-dose ACE inhibitors provide the greatest mortality benefit post-CABG, followed by statins 6. Structured cardiac rehabilitation, lipid management, and psychological support are essential components 7.

What NOT to Do

• Do not withhold beta-blockers in stable patients: Even if not on them preoperatively, initiate them postoperatively unless contraindicated
• Do not continue ACE inhibitors/ARBs through surgery: Hold preoperatively due to uncertain safety, but reinitiate aggressively postoperatively 1
• Do not rely solely on anesthetic technique: Choice of anesthetic agents is less important than pharmacologic anti-ischemic therapy 8